Analyze Diet

Topic:Placenta

The equine placenta is a vital organ that facilitates nutrient and gas exchange between the mare and the developing fetus during pregnancy. It plays a role in hormone production and immune modulation to support fetal development. The placenta in horses is classified as a diffuse, epitheliochorial type, characterized by the widespread attachment of the chorionic villi to the endometrium. Research on the equine placenta encompasses studies on its structure, function, and the physiological processes involved in its development and maintenance. This page compiles peer-reviewed research studies and scholarly articles that explore the morphology, function, and clinical implications of the placenta in equine reproduction and health.
Biosynthesis and possible biological roles of progestagens during equine pregnancy and in the newborn foal.
Equine veterinary journal. Supplement    June 1, 1997   Issue 24 89-95 doi: 10.1111/j.2042-3306.1997.tb05084.x
Chavatte P, Holtan D, Ousey JC, Rossdale PD.Major progress on the endocrinology of the pregnant mare has been possible thanks to the catheterised equine fetal preparation developed by Marian Silver. In particular, these preparations led to the identification of the source of progestagens within the feto-placental unit and provided the impetus for further work on their biosynthesis and biological activities. The biosynthesis of the progestagens involves close interaction between the fetus, the endometrium and the placenta, and gives rise to some fundamental biochemical questions. The biological role of the progestagens is also discussed:...
Microscopic anatomy of the ungulate placenta.
Equine veterinary journal. Supplement    June 1, 1997   Issue 24 7-13 doi: 10.1111/j.2042-3306.1997.tb05072.x
Macdonald AA, Fowden AL.No abstract available
Fetal calcium homeostasis.
Equine veterinary journal. Supplement    June 1, 1997   Issue 24 59-61 
Care AD.The mammalian fetus is maintained hypercalcaemic relative to its mother primarily by the action of a placental calcium pump located in the basal plasma membrane of the trophoblast. It is suggested that the activity of this pump is stimulated by a mid-molecular fragment of parathyroid hormone-related protein [PTHrP(38-94NH2)], produced in the placenta (and also in the parathyroid glands of fetal lambs and calves) as a result of post translational processing. In the sheep, calcitriol is an important determinant of fetal calcium homeostasis and it, too, stimulates the transport of calcium across ...
Placental localization of relaxin in the pregnant mare.
Placenta    March 1, 1997   Volume 18, Issue 2-3 121-128 doi: 10.1016/s0143-4004(97)90083-7
Klonisch T, Mathias S, Cambridge G, Hombach-Klonisch S, Ryan PL, Allen WR.In situ hybridization employing a cRNA probe derived from a 428-bp fragment of equine relaxin was used to localize relaxin mRNA, and immunocytochemistry was used to localize relaxin itself, in tissues of the placenta-endometrium interface recovered between 33 and 153 days of gestation from mares carrying intraspecific horse, interspecific mule and extraspecific donkey conceptuses. Immunocytochemical staining was also used to localize trophoblast-specific and class I major histocompatibility complex (MHC) antigens on some specimens. Relaxin mRNA and relaxin were both present in the single-cell ...
A developmental switch in expression from blastocyst to endometrial/placental-type cytochrome P450 aromatase genes in the pig and horse.
Biology of reproduction    March 1, 1997   Volume 56, Issue 3 688-696 doi: 10.1095/biolreprod56.3.688
Choi I, Collante WR, Simmen RC, Simmen FA.Pig blastocysts exhibit a transient period of estrogen production at periimplantation, with a second, more sustained period of estrogen synthesis occurring in endometrium and placenta at later pregnancy. Previously we reported the isolation of cDNA clones encoding a novel isoform of cytochrome P450 aromatase (the terminal enzyme in the estrogen biosynthetic pathway) from porcine periimplantation blastocysts. The present study investigated pregnancy-associated expression, in blastocysts and maternal reproductive tract tissues of this and an additional mRNA transcript encoding a distinct P450 ar...
Ultrasonographic evaluation of the equine placenta by transrectal and transabdominal approach in the normal pregnant mare.
Theriogenology    January 15, 1997   Volume 47, Issue 2 559-573 doi: 10.1016/s0093-691x(97)00014-9
Renaudin CD, Troedsson MH, Gillis CL, King VL, Bodena A.The objective of this study was to determine normal variations in the utero placental thickness during mid- and late gestation in the mare. Normal, healthy pregnant mares (n = 9) were examined monthly from 4 mo of gestation until parturition by transrectal and transabdominal ultrasonography. At each examination, the combined thickness of the uterus and the placenta (CTUP) was measured at the placento-cervical junction (transrectally) and at the uterine body or the uterine horns (transabdominally). In addition, the echogenicity of the amniotic and allantoic fluids was evaluated by transrectal u...
Studies into aromatase activity associated with fetal allantochorionic and maternal endometrial tissues of equine placenta. Identification of metabolites by gas chromatography mass spectrometry.
The Journal of steroid biochemistry and molecular biology    November 1, 1996   Volume 59, Issue 3-4 281-296 doi: 10.1016/s0960-0760(96)00115-x
Marshall DE, Dumasia MC, Wooding P, Gower DB, Houghton E.Maternal endometrial and fetal allantochorionic tissues were separated manually from the placentae of seven healthy thoroughbred and three pony mares, ranging in gestational age from 100 to 318 days. The homogeneity of subcellular fractions prepared from these tissues was assessed initially using the marker enzymes, succinate dehydrogenase, NADPH cytochrome C reductase and lactate dehydrogenase for the mitochondrial, microsomal and cytosolic fractions, respectively. Light microscopy and histochemical analysis demonstrated that the separated fetal allantochorionic membrane, which is made up of ...
Differential effect of trilostane on the progestin milieu in the pregnant mare.
Journal of reproduction and fertility    July 1, 1996   Volume 107, Issue 2 241-248 doi: 10.1530/jrf.0.1070241
Schutzer WE, Kerby JL, Holtan DW.Trilostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase, was administered intravenously to pregnant mares (n = 3) between day 277 and day 282 of gestation to determine its effect on the progestin milieu. In addition, placental tissue from mares at mid-gestation (150-300 days) (n = 4) were exposed to either deuterium-labelled pregnenolone alone or deuterium-labelled pregnenolone and trilostane to examine the effect of trilostane on placental metabolism of pregnenolone. Blood samples were collected from indwelling jugular catheters at frequent intervals for 48 h after infusion...
Analysis of MHC class I expression in equine trophoblast cells using in situ hybridization.
Placenta    July 1, 1996   Volume 17, Issue 5-6 351-359 doi: 10.1016/s0143-4004(96)90060-0
Maher JK, Tresnan DB, Deacon S, Hannah L, Antczak DF.Down-regulation of major histocompatibility complex (MHC) genes by trophoblast cells is considered to be a primary mechanism preventing maternal immune rejection of the fetal-placental unit in mammalian pregnancy by rendering these cells, which form the primary barrier between mother and fetus, relatively non-antigenic. In situ hybridization with probes encoding human and horse MHC class I genes was used to characterize the pattern of MHC class I mRNA expression in the various forms of horse trophoblast. Strong hybridization signals were observed in the invasive trophoblast cells of chorionic ...
Ever since Daisy: today’s endometrium and tomorrow’s placenta.
Equine veterinary journal    May 1, 1996   Volume 28, Issue 3 170-172 doi: 10.1111/j.2042-3306.1996.tb03768.x
Flood PF.No abstract available
Histopathological and immunofluorescent studies on transplacental infection in experimentally induced abortion by equine arteritis virus.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    April 1, 1996   Volume 43, Issue 2 65-74 doi: 10.1111/j.1439-0450.1996.tb00290.x
Wada R, Fukunaga Y, Kanemaru T, Kondo T.Five pregnant mares, at between 6 and 8 months gestation, were experimentally infected with the Bucyrus strain of equine arteritis virus (EAV). Of the five mares, four aborted and one died. The pathogenesis of the abortions was studied, using histopathologic techniques, tissue immunofluorescence and virus isolation. Common microscopic lesions in the maternal reproductive organs indicated myometritis with a degeneration of the myocytes and an infiltration of the mononuclear cells. Epithelial cells of the endometrial gland showed sporadic degeneration. Lesions in the fetal tissue included an atr...
Theriogenology question of the month. Placental insufficiency, probably the result of twin fetuses.
Journal of the American Veterinary Medical Association    January 15, 1996   Volume 208, Issue 2 201-202 
Wolfsdorf K.No abstract available
Uterine natural killer cells in species with epitheliochorial placentation.
Natural immunity    January 1, 1996   Volume 15, Issue 1 53-69 
Engelhardt H, King GJ.The epitheliochorial placenta represents the least intimate association between maternal and fetal tissues. The best known examples of this form of placentation are the domestic livestock species. Current information on the nature and proposed functions of uterine lymphocyte populations in ruminants (sheep and cattle), horses and pigs is presented. In ruminants unusual gamma delta T cells may play a role in mid to late gestation. During normal horse pregnancy, fetally derived endometrial cup cells invade the uterine stroma and are destroyed by maternal leukocytes midway through gestation. Natu...
The synthesis of 19-norandrostenedione from dehydroepiandrosterone in equine placenta is inhibited by aromatase inhibitors 4-hydroxyandrostenedione and fadrozole.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology    December 1, 1995   Volume 112, Issue 4 613-618 doi: 10.1016/0305-0491(95)00117-4
Moslemi S, Silberzahn P, Gaillard JL.19-Norandrostenedione was synthesized in vitro from dehydroepiandrosterone by explants of equine full-term placenta. The synthesis of 19-norandrostenedione was inhibited by two specific aromatase inhibitors, 4-hydroxyandrostenedione and fadrozole.
Demonstration of tissue-specific promoters in nonprimate species that express aromatase P450 in placentae.
Biology of reproduction    November 1, 1995   Volume 53, Issue 5 1151-1159 doi: 10.1095/biolreprod53.5.1151
Hinshelwood MM, Liu Z, Conley AJ, Simpson ER.Conversion of androgens to estrogens is catalyzed by aromatase P450 (P450arom; the product of the CYP19 gene). Regulation of tissue-specific expression of P450arom in humans is due, in part, to alternative transcriptional start sites that arise as a consequence of the use of granulosa cells and placental tissue from cows, horses, and pigs (ungulates) in order to determine whether these species, like the human, utilize tissue-specific promoters to drive P450arom expression. The majority of transcripts in the placenta have 5'-termini that differ from those in the ovary upstream of a common site ...
Transforming growth factor beta 1 expression in the endometrium of the mare during placentation.
Molecular reproduction and development    October 1, 1995   Volume 42, Issue 2 131-140 doi: 10.1002/mrd.1080420202
Lennard SN, Stewart F, Allen WR.In situ hybridization, Northern blotting, and immunohistochemical techniques were used to study the expression of transforming growth factor beta 1 (TGF beta 1) in the endometrium of the mare during the first 150 days of pregnancy (term = 330-340 days). In situ hybridization using an oligonucleotide (45mer) probe, based on a homologous region within all known mammalian TGF beta 1 DNA sequences, demonstrated TGF beta 1 mRNA accumulation in the glandular and lumenal epithelial cells of the endometrium from day 33 onwards which corresponds to the time of implantation (day 33-45). Expression in th...
Modulation of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in the equine placenta by pregnenolone and progesterone metabolites.
Equine veterinary journal    September 1, 1995   Volume 27, Issue 5 342-347 doi: 10.1111/j.2042-3306.1995.tb04068.x
Chavatte PM, Rossdale PD, Tait AD.The purpose of this study was to measure 3beta-HSD activity in the equine placenta and to assess the effect of fetal and maternal blood plasma progestagens on 3beta-HSD activity was measured in 8 late gestation (collected by caesarian section at 250 to 320 days) and 7 term (collected by caesarian section at 250 to 320 days) and 7 term (collected at birth) equine placentae using a tritium release assay with [3alpha-3H] pregnenolone as substrate. Mean +/- s.d. Km(app) and Vmax for term placentae were in general higher than for late gestation placentae (0.129 +/- 0.217 micromol/l and 23.85 +/- 9....
Localisation of 15-hydroxy prostaglandin dehydrogenase (PGDH) and steroidogenic enzymes in the equine placenta.
Equine veterinary journal    September 1, 1995   Volume 27, Issue 5 334-339 doi: 10.1111/j.2042-3306.1995.tb04067.x
Han X, Rossdale PD, Ousey J, Holdstock N, Allen WR, Silver M, Fowden AL, McGladdery AJ, Labrie F, Belanger A.15-hydroxy prostaglandin dehydrogenase (PGDH) is the critical enzyme that determines metabolism of primary prostaglandins. Its expression is determined in part by steroid hormones, particularly progesterone, formed from delta(5) steroids through 3beta-hydroxysteroid dehydrogenase (3beta-HSD) activity. To assess whether the regulation of PGDH might occur in a paracrine, autocrine or intracrine fashion, we used immunohistochemistry (IHC) to determine the localisation of key steroidogenic enzymes in the equine placenta and compared these patterns to the distribution of immunoreactive (IR-) PGDH. ...
EHV-1-induced abortion in mice and its relationship to stage of gestation.
Research in veterinary science    September 1, 1995   Volume 59, Issue 2 139-145 doi: 10.1016/0034-5288(95)90048-9
Awan AR, Baxi M, Field HJ.The most important consequence of equine herpesvirus-1 (EHV-1) infection is abortion. The object of the present study was to characteristic further a murine EHV-1 abortion model and to make comparisons with the natural host with particular reference to the stage of gestation during which the infection occurs. BALB/c mice at different stages of pregnancy were infected intranasally with EHV-1 (strain AB4); they suffered respiratory distress, weight loss, and other constitutional signs of infection. When the virus was inoculated in the late second or early third week of gestation dead or dying fe...
Partial complementary deoxyribonucleic acid cloning of equine relaxin messenger ribonucleic acid, and its localization within the equine placenta.
Biology of reproduction    June 1, 1995   Volume 52, Issue 6 1307-1315 doi: 10.1095/biolreprod52.6.1307
Klonisch T, Ryan PL, Yamashiro S, Porter DG.To determine the site of relaxin gene expression in equine placentae, a set of degenerate oligonucleotide primers was made according to the published amino acid sequence of the A- and B-chain of equine relaxin (eRXN). Total cellular RNA (tcRNA) from equine placentae at about 120 and 300 days of pregnancy was subjected to reverse transcriptase-polymerase chain reaction (RT-PCR) with use of these primers. A single amplification product of approximately 430 bp was detected in each case by agarose gel electrophoresis. The PCR product was ligated into Bluescript plasmid and sequenced to confirm the...
[Treatment and gestation results of mares with secondary retention].
Tijdschrift voor diergeneeskunde    May 15, 1995   Volume 120, Issue 10 300 
Berghuis GA, Wesselink HG.Twenty nine mares with retained fetal membranes were treated IV with an oxytocine infusion. Within two hours the placenta released in 24 mares (83%). Twenty six (90%) mares got pregnant during the same season.
In vitro 19-norandrogen synthesis by equine placenta requires the participation of aromatase.
The Journal of endocrinology    March 1, 1995   Volume 144, Issue 3 517-525 doi: 10.1677/joe.0.1440517
Moslemi S, Silberzahn P, Gaillard JL.Explants of equine full-term placenta have been shown to synthesize 19-norandrogens from labelled androgens. Steroid metabolites were purified by silica-gel column chromatography then analysed and quantified by c18-reverse-phase HPLC coupled to a radioactive flow detector. 19-Norandrostenedione was subsequently recrystallized to constant specific activity, providing unequivocal evidence of its synthesis by the equine placenta. 19-Norandrostenedione synthesis appeared to be localized in the microsomal fraction. Regardless of the substrate used, formation of 19-norandrogens was far weaker than t...
Horse trophoblasts produce tumor necrosis factor alpha but not interleukin 2, interleukin 4, or interferon gamma.
Biology of reproduction    March 1, 1995   Volume 52, Issue 3 531-539 doi: 10.1095/biolreprod52.3.531
Grünig G, Antczak DF.The distribution of four cytokines was analyzed in the endometrium and trophoblast of the horse between Days 30 and 55 of gestation. Endometrial tissues, invasive trophoblast (chorionic girdle), and noninvasive trophoblast (chorion and allantochorion) were examined separately. Cytokine expression was determined by amplification of specific mRNA via the reverse transcriptase polymerase chain reaction (RT-PCR). Messenger RNA for interleukin 2 (IL-2), interleukin 4 (IL-4), and interferon gamma (IFN gamma) was detected in endometrial tissues, unstimulated peripheral blood lymphocytes, and control ...
An 80-kDa syncytiotrophoblast alloantigen bound to maternal alloantibody in term placenta.
American journal of reproductive immunology (New York, N.Y. : 1989)    March 1, 1995   Volume 33, Issue 3 213-220 doi: 10.1111/j.1600-0897.1995.tb00887.x
Jalali GR, Rezai A, Underwood JL, Mowbray JF, Surridge SH, Allen WR, Matthias S.We have shown that most of the IgG present on term syncytiotrophoblast, membrane, microvesicles is bound to an 80 kDa protein antigen (R80K). Methods: Microvesicles were prepared from term human placenta, and the IgG eluted at pH3. Results: When IgG antibody was eluted at pH3 and reacted with acid-treated vesicles of other placentae, the alloantibody always bound to the preparation from which it was obtained, but only to about 10% of acid-treated preparations from other placentae. A similar polymorphic protein found in association with IgG antibody was found in term horse placentae. Cross-reac...
Insulin-like growth factor II gene expression in the fetus and placenta of the horse during the first half of gestation.
Journal of reproduction and fertility    January 1, 1995   Volume 103, Issue 1 169-179 doi: 10.1530/jrf.0.1030169
Lennard SN, Stewart F, Allen WR.Placentation in equids involves two types of trophoblast: a minor invasive component, the chorionic girdle, that gives rise to transient endocrine structures known as endometrial cups, and a major non-invasive component, the allantochorion, that forms the diffuse, microcotyledonary placenta. Growth factors are likely to be important in controlling these complex events at implantation and this study describes the use of in situ hybridization and northern blotting techniques to monitor expression of insulin-like growth factor II (IGF-II) in the fetus and placenta of the horse (Equus caballus), u...
Release of lipid from the equine placenta during in vitro incubation.
Placenta    December 1, 1994   Volume 15, Issue 8 857-872 doi: 10.1016/s0143-4004(05)80187-0
Stammers JP, Hull D, Silver M, Fowden AL, Ousey J, Rossdale PD.An in vitro incubation technique was used to examine release of lipids from the equine placenta. Placental tissue was obtained at term (n = 5, term = 320-365 days) and earlier in gestation (n = 8, mean = 266 days). Term placentae were incubated at two temperatures, 4 degrees C (control) and 37 degrees C for 2 h. Pre-term placentae were incubated at 37 degrees C with two different concentrations of fatty acid in the medium. Tissues and media were analysed for their lipid concentrations. Term and pre-term placentae released free fatty acid (FFA) and phospholipid into the incubation medium during...
[Horse with afterbirth].
Tijdschrift voor diergeneeskunde    July 1, 1994   Volume 119, Issue 13 405-406 
de Kruif A.No abstract available
The equine embryonic capsule practical implications of recent research.
Equine veterinary journal    May 1, 1994   Volume 26, Issue 3 184-186 doi: 10.1111/j.2042-3306.1994.tb04366.x
Oriol JG.In most domestic animals, the zona pellucida is the outermost extracellular layer that covers the blastocyst before implantation. However, in the horse, an acellular membrane, the capsule, replaces the zona pellucida and envelops the developing conceptus during the 2nd and 3rd weeks of gestation. Although this structure was first described by Bonnet in 1889, it received little attention until the 1970s when its rediscovery by Marrable and Flood (1975) led to a series of reports (see review by Betteridge 1989). Nevertheless, until recently the structure, origin, and function of the capsule have...
Management strategies for mares at risk for periparturient complications.
The Veterinary clinics of North America. Equine practice    April 1, 1994   Volume 10, Issue 1 237-265 doi: 10.1016/s0749-0739(17)30376-0
Vaala WE, Sertich PL.Perinatal death accounts for a large percentage of foal mortality. The most serious threats to perinatal survival remain septicemia, hypoxia, and dysmaturity. Topics discussed in this article include biochemical indices of fetoplacental function and evaluation and management of the high-risk mare.
The horse feto-placental unit.
Experimental and clinical endocrinology    January 1, 1994   Volume 102, Issue 3 166-168 doi: 10.1055/s-0029-1211277
Möstl E.In the pregnant mare two different groups of oestrogens are produced by the placenta. The precursor of "classical" oestrogens (oestrone, oestradiol-17 beta and oestradiol-17 alpha) is dehydroepiandrosterone which originates from the fetal gonads. The ring B unsaturated oestrogens (equilin and equilenin and their derivatives) derive from farnesyl pyrophosphate by a pathway not involving cholesterol.
1 7 8 9 10 11 13